Evidence map›Paper›PMID 35501501›Full record

ArticleJournal of neurology2022

Eye tracking identifies biomarkers in α-synucleinopathies versus progressive supranuclear palsy.

Mahboubeh Habibi, Wolfgang H Oertel, Brian J White, Donald C Brien, Brian C Coe, Heidi C Riek, Julia Perkins, Rachel Yep, Laurent Itti, Lars Timmermann and 4 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Journal of neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06597071 (Use of Oculometric Measures in the Differential Diagnosis of Typical and Atypical Parkinsonian Conditions), which is not on this map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06597071 naenrolling by invitationnot on this mapstarted 2024, after this paper: background citation

Use of Oculometric Measures in the Differential Diagnosis of Typical and Atypical Parkinsonian Conditions: a Pilot Study

TypeinterventionalSponsorNeuraLightRan2024 to 2025Enrolled40ConditionsParkinson Disease, Progressive Supranuclear Palsy(PSP), Multiple System AtrophyArmsNeuraLight PD, NeuraLight PSP, NeuraLight MSA, NeuraLight
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 3 countries.

Mahboubeh HabibiDepartment of Neurology, Philipps-University Marburg, 35043, Marburg, Germany. Mahbubeh.hb@gmail.com.ORCID http://orcid.org/0000-0002-1482-2158
Wolfgang H OertelDepartment of Neurology, Philipps-University Marburg, 35043, Marburg, Germany.
Brian J WhiteCentre for Neuroscience Studies, Queen's University, 18 Stuart Street, Kingston, ON, K7L 3N6, Canada.
Donald C BrienCentre for Neuroscience Studies, Queen's University, 18 Stuart Street, Kingston, ON, K7L 3N6, Canada.
Brian C CoeCentre for Neuroscience Studies, Queen's University, 18 Stuart Street, Kingston, ON, K7L 3N6, Canada.
Heidi C RiekCentre for Neuroscience Studies, Queen's University, 18 Stuart Street, Kingston, ON, K7L 3N6, Canada.
Julia PerkinsCentre for Neuroscience Studies, Queen's University, 18 Stuart Street, Kingston, ON, K7L 3N6, Canada.
Rachel YepCentre for Neuroscience Studies, Queen's University, 18 Stuart Street, Kingston, ON, K7L 3N6, Canada.
Laurent IttiDepartment of Computer Science, University of Southern California, Los Angeles, CA, USA.
Lars TimmermannDepartment of Neurology, Philipps-University Marburg, 35043, Marburg, Germany.
Christoph BestDepartment of Neurology, Philipps-University Marburg, 35043, Marburg, Germany.
Elisabeth SittigDepartment of Neurology, Philipps-University Marburg, 35043, Marburg, Germany.
Annette Janzen *Department of Neurology, Philipps-University Marburg, 35043, Marburg, Germany.
Douglas P Munoz *Centre for Neuroscience Studies, Queen's University, 18 Stuart Street, Kingston, ON, K7L 3N6, Canada. doug.munoz@queensu.ca.
Queen's University · CAPhilipps University of Marburg · DEUniversity of Southern California · US

Funding

Canadian Institutes of Health Research (CIHR) (MOP-FDN-148418)
6 · The paper itself

Abstract

objectivesThis study (1) describes and compares saccade and pupil abnormalities in patients with manifest alpha-synucleinopathies (αSYN: Parkinson's disease (PD), Multiple System Atrophy (MSA)) and a tauopathy (progressive supranuclear palsy (PSP)); (2) determines whether patients with rapid-eye-movement sleep behaviour disorder (RBD), a prodromal stage of αSYN, already have abnormal responses that may indicate a risk for developing PD or MSA.

methodsNinety (46 RBD, 27 PD, 17 MSA) patients with an αSYN, 10 PSP patients, and 132 healthy age-matched controls (CTRL) were examined with a 10-min video-based eye-tracking task (Free Viewing). Participants were free to look anywhere on the screen while saccade and pupil behaviours were measured.

resultsPD, MSA, and PSP spent more time fixating the centre of the screen than CTRL. All patient groups made fewer macro-saccades (> 2

conclusionRBD patients already have discrete but less pronounced saccade abnormalities than PD and MSA patients. Vertical gaze palsy and altered pupil control differentiate PSP from αSYN.

Indexed as

Multiple System AtrophyParkinson DiseaseSupranuclear Palsy, ProgressiveSynucleinopathiesBiomarkersEye-Tracking TechnologyHumansBiomarkersAlpha-synucleinopathyBiomarkerEye movementMultiple system atrophyParkinson’s diseaseProgressive supranuclear palsyREM sleep behaviour disorder

Identifiers

PMID35501501
PMCPMC9363304
OpenAlexW4225276541

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.